0000000000480800

AUTHOR

Montserrat Ferrer

showing 18 related works from this author

Polypyridyl-functionalizated alkynyl gold(i) metallaligands supported by tri- and tetradentate phosphanes

2017

A series of alkynyl gold(I) tri and tetratopic metallaligands of the type [Au3(CuC-R)3(μ3-triphosphane)] (R = 2,2'-bipyridin-5-yl or C10H7N2, 2,2':6',2''-terpyridin-4-yl or C15H10N3; triphosphane = 1,1,1-tris(diphenylphosphanyl) ethane or triphos, 1,3,5-tris(diphenylphosphanyl)benzene or triphosph) and [Au4(CuC-R)4 (μ4-tetraphosphane)] (R = C10H7N2, C15H10N3; tetraphosphane = tetrakis(diphenylphosphanylmethyl)methane or tetraphos, 1,2,3,5-tetrakis(diphenylphosphanyl)benzene or tpbz, tetrakis(diphenylphosphaneylmethyl)-1,2- ethylenediamine or dppeda) were obtained in moderate to good yields. All complexes could be prepared by a Q4 reaction between the alkynyl gold(I) polymeric species [Au(Cu…

DenticityStereochemistryOrCrystal structureLigands010402 general chemistry01 natural sciencesMedicinal chemistryInorganic Chemistrychemistry.chemical_compoundcoordination complexesta116kemiallinen synteesiligands010405 organic chemistryChemistryLigandAromaticitykompleksiyhdisteetliganditNuclear magnetic resonance spectroscopyTriphos0104 chemical sciencesLligandsTriphosphaneCompostos d'orIntramolecular forceGoldGold compoundschemical synthesisDalton Transactions
researchProduct

MOESM4 of Clinical interval and diagnostic characteristics in a cohort of bladder cancer patients in Spain: a multicenter observational study

2017

Additional file 4. Characteristics of bladder cancer patients by hospitals.

urologic and male genital diseasesfemale genital diseases and pregnancy complications
researchProduct

Base-assisted synthesis of 4-pyridinate gold(I) metallaligands: a study of their use in self-assembly reactions

2021

Made available in DSpace on 2021-06-25T12:16:58Z (GMT). No. of bitstreams: 0 Previous issue date: 2021-05-06 Ministerio de Economia y Competitividad (MINECO/FEDER) of Spain Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) The synthesis of di- and tritopic gold(I) metallaligands of the type [(Au4-py)(2)(mu(2)-diphosphane)] (diphosphane = bis(diphenylphosphanyl)isopropane or dppip (1), 1,2-bis(diphenylphosphanyl)ethane or dppe (2), 1,3-bis(diphenylphosphanyl)propane or dppp (3) and 1,4-bis(diphenylphosphanyl)butane or dppb (4)) and [(Au4-py)(3)(mu(3)-triphosphane)] (triphosphane = 1,1,1-tris(diphenylphosph…

chemistry.chemical_elementOrNuclear magnetic resonance spectroscopyLigandsMedicinal chemistryAcceptorComplexos metàl·licsTriphosInorganic ChemistryTrigonal bipyramidal molecular geometrychemistry.chemical_compoundTriphosphaneLligandschemistryMetal complexesDiphosphaneGoldPlatinumPalladium
researchProduct

MOESM1 of Clinical interval and diagnostic characteristics in a cohort of bladder cancer patients in Spain: a multicenter observational study

2017

Additional file 1. List of Ethic Committees that approved the study.

ComputingMilieux_THECOMPUTINGPROFESSIONData_FILESComputingMilieux_LEGALASPECTSOFCOMPUTINGGeneralLiterature_REFERENCE(e.g.dictionariesencyclopediasglossaries)
researchProduct

Bladder cancer index: cross-cultural adaptation into Spanish and psychometric evaluation.

2014

Background: The Bladder Cancer Index (BCI) is so far the only instrument applicable across all bladder cancer patients, independent of tumor infiltration or treatment applied. We developed a Spanish version of the BCI, and assessed its acceptability and metric properties. Methods: For the adaptation into Spanish we used the forward and back-translation method, expert panels, and cognitive debriefing patient interviews. For the assessment of metric properties we used data from 197 bladder cancer patients from a multi-center prospective study. The Spanish BCI and the SF-36 Health Survey were self-administered before and 12 months after treatment. Reliability was estimated by Cronbach’s alpha.…

MalePsychometricsAparell urinariSurveys and QuestionnairesProspective cohort studyCàncermedia_commonLanguageCognitionGeneral MedicinePatient outcomeControl de qualitatNeoplasias de la Vejiga UrinariaEstudios de ValidaciónPsicometríaBufeta -- CàncerFemalePsicometriaClinical psychologyCross-Cultural ComparisonQuality of lifemedicine.medical_specialtyPsychometricsUrinary bladder neoplasms:Psychiatry and Psychology::Behavioral Disciplines and Activities::Psychological Tests::Psychometrics [Medical Subject Headings]:Publication Characteristics::Study Characteristics::Validation Studies [Medical Subject Headings]Cronbach's alpha:Disciplines and Occupations::Social Sciences::Quality of Life [Medical Subject Headings]medicine:Diseases::Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Urologic Neoplasms::Urinary Bladder Neoplasms [Medical Subject Headings]media_common.cataloged_instanceHumansEuropean UnionEuropean unionAgedNeoplasm StagingGynecologyAnalysis of VarianceBladder cancerbusiness.industryResearchPublic Health Environmental and Occupational HealthConstruct validityTranslatingmedicine.diseaseCross-cultural studiesUnited StatesValidation studiesPatient outcomesCalidad de VidabusinessHealth and quality of life outcomes
researchProduct

MOESM3 of Clinical interval and diagnostic characteristics in a cohort of bladder cancer patients in Spain: a multicenter observational study

2017

Additional file 3. Diagnostic tests for bladder cancer patients.

urologic and male genital diseasesfemale genital diseases and pregnancy complications
researchProduct

Clinical interval and diagnostic characteristics in a cohort of bladder cancer patients in Spain : a multicenter observational study

2017

Objective We performed a cohort study in seven hospitals in Spain to determine the clinical characteristics of incident patients with bladder cancer, the diagnostic process, and the conditions that might affect health care interval times. Results 314 patients with bladder cancer were included, 70.3 (Standard Deviation [SD] 11.2) years old and 85.0% male. Clinical stage was T1 in 45.9% of patients. The median interval time between first consultation and diagnosis was of 104.0 days (Inter quartile range [IQR]:112.0; range from 0 to 986), being shorter for those patients who attended a hospital for their first consultation. The median interval time between diagnosis and first treatment was of …

Malemedicine.medical_specialty030232 urology & nephrologylcsh:MedicineGeneral Biochemistry Genetics and Molecular BiologyCohort Studies03 medical and health sciences0302 clinical medicineInterquartile rangeInternal medicineObservational studyTumor stageHealth careDiagnostic techniques and proceduresmedicineUrinary bladder neoplasmHumansStage (cooking)lcsh:Science (General)lcsh:QH301-705.5AgedAged 80 and overBladder cancerbusiness.industryTime factorslcsh:RGeneral MedicineMiddle Agedmedicine.diseaseResearch Notelcsh:Biology (General)Urinary Bladder NeoplasmsSpain030220 oncology & carcinogenesisCohortNeoplasm stagingObservational studyFemaleBufeta -- CàncerbusinessCohort studylcsh:Q1-390
researchProduct

MOESM2 of Clinical interval and diagnostic characteristics in a cohort of bladder cancer patients in Spain: a multicenter observational study

2017

Additional file 2. Patients’ structured interview.

researchProduct

Gold(I)-doped films: new routes for efficient room temperature phosphorescent materials

2021

The synthesis of four novel gold(I)-phosphane complexes coordinated to 9-phenanthrene chromophore has been carried out through the reaction of 9-phenanthreneboronic acid and the corresponding AuClPR3 (PR3 = PPh3 for triphenylphosphane (1a); 1,4-bis(diphenylphosphanyl)butane or dppb (2b); bis(diphenylphosphanyl)acetylene or dppa (2c); (AuCl)2(diphos) (diphos = bis(diphenylphosphanyl)methane or dppm (3)) sources. The X-ray crystal structures of compounds 1a and 2b show the existence of MOF-like intermolecular assemblies that contain empty inner cavities in the absence of aurophilic contacts. In contrast, the formation of a tetranuclear complex with intramolecular aurophilic interactions was e…

LuminescenceLigandQuímica organometàl·licaLuminescènciaOrCrystal structureChromophoreFluorescenceInorganic Chemistrychemistry.chemical_compoundAcetylenechemistryOrganometallic chemistryIntramolecular forcePolymer chemistryGoldLuminescencePhosphorescence
researchProduct

CCDC 2031247: Experimental Crystal Structure Determination

2021

Related Article: Araceli de Aquino, Francisco J. Caparrós, Khai-Nghi Truong, Kari Rissanen, Montserrat Ferrer, Yongsik Jung, Hyeonho Choi, João Carlos Lima, Laura Rodríguez|2021|Dalton Trans.|50|3806|doi:10.1039/D1DT00087J

bis(mu-bis(diphenylphosphino)methyl)-bis(phenanthren-9-yl)-tetra-gold unknown solvateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 2000612: Experimental Crystal Structure Determination

2021

Related Article: Montserrat Ferrer, Albert Gutiérrez, Manuel Martínez, Cristiana Da Silva, Adelino V. G. Netto, Laura Rodríguez, Guillermo Romo-Islas, Fangfang Pan, Kari Rissanen|2021|Dalton Trans.|50|8154|doi:10.1039/D1DT00402F

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parameters(mu-12-bis(diphenylphosphino)ethane)-bis(pyridin-4-yl)-di-goldExperimental 3D Coordinates
researchProduct

CCDC 1561541: Experimental Crystal Structure Determination

2017

Related Article: Montserrat Ferrer, Leticia Giménez, Albert Gutiérrez, João Carlos Lima, Manuel Martínez, Laura Rodríguez, Avelino Martín, Rakesh Puttreddy, Kari Rissanen|2017|Dalton Trans.|46|13920|doi:10.1039/C7DT02732J

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parameters(mu-tetrakis((diphenylphosphino)methyl)methane)-tetrakis((22'-bipyridine-5-yl)ethynyl)-tetra-gold dichloromethane solvateExperimental 3D Coordinates
researchProduct

CCDC 1559283: Experimental Crystal Structure Determination

2017

Related Article: Montserrat Ferrer, Leticia Giménez, Albert Gutiérrez, João Carlos Lima, Manuel Martínez, Laura Rodríguez, Avelino Martín, Rakesh Puttreddy, Kari Rissanen|2017|Dalton Trans.|46|13920|doi:10.1039/C7DT02732J

Space GroupCrystallographyCrystal System(mu-(benzene-1245-tetrayl)tetrakis(diphenylphosphane))-tetrakis(22'-bipyridin-5-ylethynyl)-tetra-gold unknown solvateCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 2000611: Experimental Crystal Structure Determination

2021

Related Article: Montserrat Ferrer, Albert Gutiérrez, Manuel Martínez, Cristiana Da Silva, Adelino V. G. Netto, Laura Rodríguez, Guillermo Romo-Islas, Fangfang Pan, Kari Rissanen|2021|Dalton Trans.|50|8154|doi:10.1039/D1DT00402F

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parametersbis(mu-bis(diphenylphosphino)methyl)-bis(4-pyridyl)-tetra-gold(i) dichloromethane solvateExperimental 3D Coordinates
researchProduct

CCDC 2000613: Experimental Crystal Structure Determination

2021

Related Article: Montserrat Ferrer, Albert Gutiérrez, Manuel Martínez, Cristiana Da Silva, Adelino V. G. Netto, Laura Rodríguez, Guillermo Romo-Islas, Fangfang Pan, Kari Rissanen|2021|Dalton Trans.|50|8154|doi:10.1039/D1DT00402F

Space GroupCrystallography(mu-13-bis(diphenylphosphino)propane)-bis(pyridin-4-yl)-di-goldCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 2019745: Experimental Crystal Structure Determination

2021

Related Article: Araceli de Aquino, Francisco J. Caparrós, Khai-Nghi Truong, Kari Rissanen, Montserrat Ferrer, Yongsik Jung, Hyeonho Choi, João Carlos Lima, Laura Rodríguez|2021|Dalton Trans.|50|3806|doi:10.1039/D1DT00087J

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parameters(phenanthren-9-yl)-(triphenylphosphine)-gold(i)Experimental 3D Coordinates
researchProduct

CCDC 2031248: Experimental Crystal Structure Determination

2021

Related Article: Araceli de Aquino, Francisco J. Caparrós, Khai-Nghi Truong, Kari Rissanen, Montserrat Ferrer, Yongsik Jung, Hyeonho Choi, João Carlos Lima, Laura Rodríguez|2021|Dalton Trans.|50|3806|doi:10.1039/D1DT00087J

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parameters{mu-butane-14-diylbis(diphenylphosphine)}-bis(phenanthren-9-yl)-di-goldExperimental 3D Coordinates
researchProduct

CCDC 2000614: Experimental Crystal Structure Determination

2021

Related Article: Montserrat Ferrer, Albert Gutiérrez, Manuel Martínez, Cristiana Da Silva, Adelino V. G. Netto, Laura Rodríguez, Guillermo Romo-Islas, Fangfang Pan, Kari Rissanen|2021|Dalton Trans.|50|8154|doi:10.1039/D1DT00402F

Space GroupCrystallographyCrystal Systembis(mu-111-tris((diphenylphosphino)methyl)ethane)-hexakis(4-pyridyl)-hexa-gold unknown solvateCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct